UroGen Pharma Ltd.
Status: Publicly traded
Direct answer
UroGen Pharma Ltd. is publicly traded on NASDAQ under the ticker URGN.
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a...
Can you invest in UroGen Pharma Ltd.?
Yes. UroGen Pharma Ltd. trades publicly on NASDAQ as URGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for UroGen Pharma Ltd.
Detailed equity research is provided by MarketSnap.